2017 Pediatric Rx, Module 4- GI Drugs
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hours, of which 0.5 is pharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com
Copyright 2017 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Participants will have up-to-date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
- Participants will be able to critically evaluate the safety and efficacy of GI drugs in children, such as proton pump inhibitors.
Teri Moser Woo, PhD, CPNP-BC, CNL, FAANP: Associate Dean for Graduate Nursing Programs, Pacific Lutheran University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
Dr. Moser Woo has no relevant financial relationships to disclose.
- 0.50 Contact hours